Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60.8K Hold
153
﹤0.01% 233
2026
Q1
$26.5K Hold
153
﹤0.01% 302
2025
Q4
$39.2K Hold
153
﹤0.01% 256
2025
Q3
$39.8K Hold
153
﹤0.01% 263
2025
Q2
$37.4K Hold
153
﹤0.01% 260
2025
Q1
$40.5K Hold
153
﹤0.01% 237
2024
Q4
$38.8K Buy
153
+60
+65% +$16.1K ﹤0.01% 238
2024
Q3
$29.5K Buy
+93
New +$33.1K ﹤0.01% 262
2017
Q1
Sell
-50
Closed -$10K 318
2016
Q4
$10K Hold
50
﹤0.01% 265
2016
Q3
$9K Hold
50
﹤0.01% 265
2016
Q2
$9K Hold
50
﹤0.01% 255
2016
Q1
$9K Sell
50
-50
-50% -$8.67K ﹤0.01% 258
2015
Q4
$18K Hold
100
﹤0.01% 281
2015
Q3
$18K Hold
100
﹤0.01% 277
2015
Q2
$19K Hold
100
﹤0.01% 254
2015
Q1
$18K Hold
100
﹤0.01% 241
2014
Q4
$15K Hold
100
﹤0.01% 271
2014
Q3
$13K Hold
100
﹤0.01% 284
2014
Q2
$13K Buy
+100
New +$11.8K ﹤0.01% 256

Other funds holding HUM

Atwood & Palmer's HUM Position: Q2 2026 in Review

Atwood & Palmer held its Humana (HUM) position steady in Q2 2026 at 153 shares worth $60.8K. The position accounts for ﹤0.01% of the portfolio, ranked #233.

Atwood & Palmer first reported a position in HUM in Q2 2014 and has held it in 19 quarters since. 925 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Atwood & Palmer held 153 shares of Humana worth $60.8K as of Q2 2026.
  • Atwood & Palmer left its Humana share count unchanged in Q2 2026.
  • Humana made up ﹤0.01% of Atwood & Palmer's portfolio in Q2 2026, its #233 holding.
  • Atwood & Palmer first reported a position in Humana in Q2 2014 and has held it in 19 quarters since.
  • 925 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Atwood & Palmer's 13F filing for Q2 2026, filed 8 Jul 2026.